The objectives of this study were to observe the effects of immunization with mouse mature adipocytes for the prevention of obesity in rats and to investigate their mechanism of action. Mouse mature adipocytes (3T3-L1) were injected as a vaccine into the abdominal cavity of rats. Control rats were injected with fibroblast cell lines (MRC-5 or NIH/3T3) or with 0.9% saline. Rats were fed a high calorie diet and body weight changes were used to evaluate obesity prevention. Immuno histochemical and immunofluorescence assays were used to investigate the mechanism of action. Results showed that obesity in rats can be prevented by immunization with xenogeneic mature mouse adipocytes. Body weight gain was inhibited in rats in the treatment group but not in the control groups and was statistically significant between the groups over the 19-week observation period. The assays demonstrated the presence of auto antibodies in rat adipocytes. It was concluded that vaccines of xenogeneic adipocytes can effectively prevent obesity in rats.
Introduction
Obesity is a global health problem causing premature morbidity and mortality, influencing quality of living and increasing national financial burden. 1 It is a primary risk factor for various chronic diseases and psychosocial disorders, such as hypertension, hyperlipidaemia, diabetes mellitus, cardiovascular disease and obstructive sleep apnoea syndrome. Obesity occurs when calorie intake exceeds that of consumption, resulting in excess calories being stored in the body in the form of fat. 2 A body mass index (calculated by body weight [kg]/height 2 [m 2 ]) of 25.0 -29.9 kg/m 2 is categorized as overweight and > 30.0 kg/m 2 is categorized as obese. 3 It has been shown that obesity results from an increase in the volume and number of adipocytes. 4 Changes in cell volume are mainly due to lipogenesis and lipolysis, while an increase in cell number results from proliferation and differentiation of proadipocytes and the proliferation of mature adipocytes. 5 
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other possible mechanisms such as dedifferentiation. Adipocytes from patients who are obese show characteristics of overproliferation after dedifferentiation. Under physiological conditions, increases and decreases in cell numbers are normally balanced and only when the increase exceeds the decrease does obesity ensue.
Neuropeptide Y (NPY) is thought to be the most potent substance stimulating the appetite centre. 6, 7 Intracerebroventricular administration of antisense oligodeoxyribonucleotide NPY-Y5 by lateral ventricle intubation has been shown to result in apoptosis of adipocytes and lipolysis. 8 Leptin, a peptide hormone produced by adipocytes, may modulate the metabolism and number of adipocytes through interaction with the corresponding receptors in the hypothalamus; 9 however, as no leptin receptor has been identified to date, leptin is considered not to have a direct effect on adipocyte catabolism. Gullicksen et al. 10 demonstrated that intracerebroventricular injection of leptin not only induces adipocyte apoptosis, but also decreases adipocyte cell volume. Since intracerebroventricular injection of NPY and leptin is required to induce adipocyte apoptosis, the procedure is complex, expensive, high risk and clinically impractical. As a result, an effective and practical means of inducing apoptosis in pro-adipocytes and mature adipocytes is a key issue in obesity research.
In order to try to inhibit the proliferation and differentiation of pro-adipocytes and to proliferate mature adipocytes with minimum side effects, immunotherapy techniques were used in the present study that have successfully been used in tumour management to suppress the proliferation of tumour cells and vascular endothelial cells. Previous studies have induced an intensive cross-immune reaction by overcoming self antigen tolerance thereby inducing apoptosis of tumour endothelial cells and tumour cells. 11 -17 A similar strategy was employed in the present study, whereby tolerance to adipocytes was overcome by positive immunization with fixed xenogeneic mature adipocytes, which induced a cross-immune reaction to autologous adipocytes and apoptosis of adipocytes.
Materials and methods

MOUSE 3T3-L1 CULTURE AND DIFFERENTIATION
Mouse 3T3-L1 pre-adipocyte cells (American Type Culture Collection, Manassas, VA, USA) were cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco ® -BRL, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 0.1 mg/ml streptomycin at 37°C under 5% carbon dioxide. The medium was changed every 3 days until cells reached 70% confluence when they were passaged by trypsinization.
Mouse 3T3-L1 pro-adipocyte differentiation was induced by classic 'steroid cocktail' induction. On the second day of complete cell aggregation (day 0 of differentiation induction), the following differentiation inducers were added: 0.5 mmol/l methylxanthine, 10 µmol/l dexa methasone and 2 mg/l insulin (Sigma-Aldrich, St Louis, MO, USA). After 48 h incubation with inducer, the medium was changed to contain only 2 mg/l insulin and no inducer. The culture was maintained for 2 weeks.
HUMAN MRC-5 AND MOUSE NIH/3T3 CULTURE
The control human fibroblast cell line, MRC-5, and the mouse fibroblast cell line, NIH/3T3 (American Type Culture Collection), were cultured in DMEM containing 10% fetal bovine serum, 100 Q-G Lai, B-Q Jiang, X-H Zhou et al. Xenogeneic adipocyte vaccine for obesity prevention in rats U/ml penicillin and 0.1 mg/ml streptomycin. The cells were incubated at 37°C in humid atmospheric conditions containing 5% carbon dioxide. Cells that reached 80% confluence were suspended for passage.
VACCINE PREPARATION
The in vitro cultured and amplified cells (adipocytes and control fibroblasts), were placed in separate centrifuge tubes and washed with phosphate-buffered saline (PBS), pH 7.4 (final concentrations, 137 mM sodium chloride, 10 mM sodium phosphate, 2.7 mM potassium chloride). The cells were then fixed with stationary fluid (4% paraformaldehyde) at 4°C for 24 h, washed three times with PBS and incubated in 0.9% saline at 37°C for 2 h to remove all residual paraformaldehyde. A cell suspension was then prepared with PBS and the cells were counted using a blood cell counting plate. The cells were then suspended in 0.9% saline at a concentration of 10 6 cells/ml. The resulting pro-adipocyte xenogeneic vaccine and control fibroblast cell line vaccines were stored in sealed centrifuge tubes at -80°C prior to use.
IMMUNIZATION OF RATS
Female and male Sprague Dawley (SD) rats aged 6 -8 weeks were randomly assigned to separate-gender treatment and control groups (10 rats/group; 4 groups/gender). Each rat was housed separately in a cage in clean conditions with free access to food and water. The experimental protocol was approved by the Animal Care Committee of Shandong University.
In the treatment groups, 1 ml of the mouse adipocyte cell line, 3T3-L1, at a concentration of 10 6 cells/ml was injected into the abdominal cavity once a week for 4 weeks. Control groups received 1 ml of one of the fibroblast cell lines, MRC-5 or NIH/3T3, or 0.9% saline in a similar manner once a week for 4 weeks. After the fourth immunization, all rats were fed a high calorie diet, comprising 25% raw protein, 11% fat and 64% carbohydrate. Body weight changes in the treatment and control groups were analysed. The rats were sacrificed 19 weeks after immunization.
DETECTION OF AUTOANTIBODY DEPOSITION
Intra-abdominal adipose tissue from sacrificed immunized rats was sectioned to determine in vivo autoantibody deposition in mature adipocytes. Immunohisto chemical assay was carried out using sera from immunized and non-immunized (control) rats as the primary antibody to stain adipocytes from immunized rats, with incubation for 1 h at room temperature. Peroxidase-labelled rabbit antirat antibody was used as the secondary antibody. Incubation was for 30 min at room temperature and diaminobenzidine was the stain.
DETECTION OF ADIPOCYTE APOPTOSIS
Immunofluorescence staining of adipocyte tissue used the terminal deoxynucleotidyl transferase-mediated 2′-deoxyuridine-5′triphosphate (dUTP) nick-end labelling (TUNEL) procedure to detect subcutaneous adipocyte apoptosis in vivo in the abdominal wall of both treatment and control groups, as described by Tan et al. 18 
STATISTICAL ANALYSIS
Body weight changes in the treatment and control groups were analysed using the parametric rank sum test. The StatGraphics ® statistical graphics software system (STSC, Rockville, MD, USA) was used to test for significance. A P-value < 0.05 was considered statistically significant.
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Results
BODY WEIGHT CHANGES
Body weight-time curves for male and female rats in the treatment and control groups are shown in Figs 1A and 1B , respectively. Male and female rats immunized with the xenogeneic adipocyte cell line 3T3-L1 (treatment group) showed statistically significant (P < 0.05) inhibition of body weight gain over the 19-week observation period compared with rats immunized with the fibroblast cell lines (MRC-5 and NIH/3T3) or with the 0.9% saline (control groups). The control groups all showed normal gains in 
AUTOANTIBODY DEPOSITION
Immunohistochemical assay of adipocyte tissue revealed autoantibody deposition in vivo only in mature adipocytes from rats in the treatment (mouse 3T3-L1 adipocyte vaccine) group (Fig. 2 ).
ADIPOCYTE APOPTOSIS
The TUNEL immunofluorescence assay detected apoptosis of adipocytes in vivo only in the treatment (mouse 3T3-L1 proadipocyte vaccine) group (Fig. 3 ).
Discussion
In terms of positive immunotherapy, an immune response is difficult to achieve if autologous or allogeneic cells, proteins or genes are used as the antigen vaccine. This is because immune tolerance to such antigens (especially to autologous antigens) is acquired during development of the immune system. Immune tolerance to autologous antigens can be overcome by a combination of xenogeneic homologous genes, xenogeneic immunological rejection and the autoimmune reaction. 11 It has been shown that the autoimmune reaction to mouse tumour vascular endothelial cells may be successfully induced by immunization with xenogeneic vascular endothelial cells; antitumour activity without adverse effects was reported. 11 Additionally, to investigate the xenogeneic homologous cross-immune reaction, vascular endothelial growth factor, epidermal growth factor receptor, matrix metalloproteinase-2, fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 have been cloned to develop xenogeneic nucleic acid and protein vaccines. 12 -17,19 -22 By overcoming immune tolerance and inducing an interspecies cross-immune reaction, such vaccines have been used successfully to treat tumour-bearing mice, and have demonstrated that immunotherapy with xenogeneic homologous genes and proteins can overcome immune tolerance to self antigen and induce an intensive cross-immune reaction, resulting in apoptosis of tumour cells and vascular endothelial cells. 19 -23 Based on the theory that xenogeneic homologous cells, protein molecules, and nucleic acid molecules have evolved with similar structures and can cause immunological rejection, we propose that xenogeneic adipocytes may potentially be used as vaccines to prevent obesity.
Immunoprophylaxis offers several advantages, such as improved tolerability, a significant curative effect and 'oncevaccination-lifetime-protection'. To our knowledge, there is no previous report on the use of immunotherapy to inhibit adiposity that suggests using immunotherapy for the treatment and prevention of obesity. The present study used methods that had previously been successful in inducing apoptosis of tumour cells and endothelial cells were used to design a method to induce apoptosis of mature adipocytes. By monitoring body weight changes in immunized rats, xenogeneic mouse adipocytes were found to prevent adiposity. Male and female rats immunized with xenogeneic adipocytes showed significant inhibition of body weight gain compared to the body weight gain in control rats immunized with fibroblast cell lines or saline. Immunohistochemical staining of rat adipose tissues revealed autoantibodies in the mature adipocytes of immunized rats, which mediated the cross-immune reaction and overcame immune tolerance to autologous adipocytes. Additionally, apoptosis was detected with TUNEL Q-G Lai, B-Q Jiang, X-H Zhou et al.
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immunofluorescence assay, confirming that the cross-immune reaction was induced by xenogeneic mouse adipocytes.
By employing distinct techniques in the field of tumour treatment, the present study has widened the application of 
